2017 Publications

 

1. Sphingosine kinase 2 activates autophagy and protects neurons against ischemic injury through interaction with Bcl-2 via its putative BH3 domain

Song, D., Zhang, T., Chen, J., Xia, Y., Qin, Z., Waeber, C., & Sheng, R. (2017). Sphingosine kinase 2 activates autophagy and protects neurons against ischemic injury through interaction with bcl-2 via its putative BH3 domain. Cell Death & Disease, 8(7), e2912-e2912.

 

2. Cerebral Blood Flow Methods

C.Waeber , Primer on Cerebrovascular Diseases (Second Edition), 2017, Pages 324-327.


  

3. Sphingosine 1-phosphate (S1P) signalling: Role in bone biology and potential therapeutic target for bone repair

Sartawi, Z., Schipani, E., Ryan, K. B., & Waeber, C. (2017). Sphingosine 1-phosphate (S1P) signalling: Role in bone biology and potential therapeutic target for bone repair. Pharmacological Research, 125(Pt B), 232-245.

 

 

4. Data on the regulation of moesin and merlin by the urokinase receptor (uPAR): Model explaining distal activation of integrins by uPAR.

 Degryse, B., Britto, M., Shan, C. X., Wallace, R. G., Rochfort, K. D., Cummins, P. M., Meade, G., & Murphy, R. P. (2017). Data on the regulation of moesin and merlin by the urokinase receptor (uPAR): Model explaining distal activation of integrins by uPAR. Data in Brief, 15, 600-605

 

 

5. Non-insulin antidiabetic pharmacotherapy in patients with established cardiovascular disease

Niessner, A., Tamargo, J., Koller, L., Saely, C. H., Schmidt, T. A., Savarese, G., Wassmann, S., Rosano, G., Ceconi, C., Torp-Pedersen, C., Kaski, J. C., Kjeldsen, K. P., Agewall, S., Walther, T., Drexel, H., & Lewis, B. S. (2018). Non-insulin antidiabetic pharmacotherapy in patients with established cardiovascular disease: A position paper of the european society of cardiology working group on cardiovascular pharmacotherapy. European Heart Journal, 39(24), 2274-2281 

 

 

6. Angiotensin-(1-7) counteracts the transforming effects triggered by angiotensin II in breast cancer cells

 Cambados, N., Walther, T., Nahmod, K., Tocci, J. M., Rubinstein, N., Boehme, I., Simian, M., Sampayo, R., Del Valle Suberbordes, M., Kordon, E. C., & Schere-Levy, C. (2017). Angiotensin-(1-7) counteracts the transforming effects triggered by angiotensin II in breast cancer cells.

 

 

7.Acceptability of microneedle-patch vaccines: A qualitative analysis of the opinions of parents.

Marshall, S., Fleming, A., Moore, A. C., & Sahm, L. J. (2017). Acceptability of microneedle-patch vaccines: A qualitative analysis of the opinions of parents. Vaccine, 35(37), 4896-4904.

 

 

8. Comprehensive efforts to increase adherence to statin therapy

Vonbank, A., Agewall, S., Kjeldsen, K. P., Lewis, B. S., Torp-Pedersen, C., Ceconi, C., Funck-Brentano, C., Kaski, J. C., Niessner, A., Tamargo, J., Walther, T., Wassmann, S., Rosano, G., Schmidt, H., Saely, C. H., & xel, H. (2017). Comprehensive efforts to increase adherence to statin therapy. European Heart Journal, 38(32), 2473-2477b. 

 

 

9. Sphingosine kinase 2 activates autophagy and protects neurons against ischemic injury through interaction with Bcl-2 via its putative BH3 domain

Song, D., Zhang, T., Chen, J., Xia, Y., Qin, Z., Waeber, C., & Sheng, R. (2017). Sphingosine kinase 2 activates autophagy and protects neurons against ischemic injury through interaction with bcl-2 via its putative BH3 domain. Cell Death & Disease, 8(7), e2912-e2912 

 

 

10. Moesin and Merlin Regulate Urokinase Receptor-Dependent Endothelial Cell Migration, Adhesion and Angiogenesis

Degryse, B., Britto, M., Shan, C. X., Wallace, R. G., Rochfort, K. D., Cummins, P. M., Meade, G., & Murphy, R. P. (2017). Moesin and merlin regulate urokinase receptor-dependent endothelial cell migration, adhesion and angiogenesis. The International Journal of Biochemistry & Cell Biology, 88, 14-22.

 

 

11. Gender differences in the effects of cardiovascular drugs

Tamargo, J., Rosano, G., Walther, T., Duarte, J., Niessner, A., Kaski, J. C., Ceconi, C., Drexel, H., Kjeldsen, K., Savarese, G., Torp-Pedersen, C., Atar, D., Lewis, B. S., & Agewall, S. (2017). Gender differences in the effects of cardiovascular drugs. European Heart Journal. Cardiovascular Pharmacotherapy, 3(3), 163-182.

 

 

12. Mas receptor is involved in the estrogen-receptor induced nitric oxide-dependent vasorelaxation

Sobrino, A., Vallejo, S., Novella, S., Lázaro-Franco, M., Mompeón, A., Bueno-Betí, C., Walther, T., Sánchez-Ferrer, C., Peiró, C., & Hermenegildo, C. (2017). Mas receptor is involved in the estrogen-receptor induced nitric oxide-dependent vasorelaxation. Biochemical Pharmacology, 129, 67-72 

 

 

13. Further intracellular proteins and signaling pathways regulated by angiotensin-(1-7) in human endothelial cells

Meinert, C., Kohse, F., Böhme, I., Gembardt, F., Tetzner, A., Wieland, T., Greenberg, B., & Walther, T. (2017;2016;). Further intracellular proteins and signaling pathways regulated by angiotensin-(1–7) in human endothelial cells. Data in Brief, 10(C), 354-363. 

 

 

14. Data on the regulation of moesin and merlin by urokinase: Model explaining distal activation of integrins by the uPAR. 

Degryse, B., Britto, M., Shan, C. X., Wallace, R. G., Rochfort, K. D., Cummins, P. M., Meade, G., & Murphy, R. P. (2017). Data on the regulation of moesin and merlin by the urokinase receptor (uPAR): Model explaining distal activation of integrins by uPAR. Data in Brief, 15, 600-605 

 

Department of Pharmacology and Therapeutics

Cógaseolaíocht agus Teiripic

Room 2.36B, 2nd Floor, Western Gateway Building, University College Cork, Cork

Top